CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 54 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $74,000 | -43.5% | 13,583 | -68.8% | 0.00% | – |
| Q3 2019 | $131,000 | -29.2% | 43,578 | -12.1% | 0.00% | – |
| Q2 2019 | $185,000 | -2.6% | 49,578 | +4.6% | 0.00% | – |
| Q1 2019 | $190,000 | +9.8% | 47,378 | +0.6% | 0.00% | – |
| Q4 2018 | $173,000 | -56.6% | 47,078 | +1.3% | 0.00% | -100.0% |
| Q3 2018 | $399,000 | -18.7% | 46,478 | +4.0% | 0.00% | 0.0% |
| Q2 2018 | $491,000 | -3.9% | 44,678 | +0.9% | 0.00% | 0.0% |
| Q1 2018 | $511,000 | +293.1% | 44,278 | +312.1% | 0.00% | – |
| Q2 2017 | $130,000 | -73.9% | 10,744 | -55.3% | 0.00% | -100.0% |
| Q1 2017 | $499,000 | +56.9% | 24,049 | +8.1% | 0.00% | 0.0% |
| Q4 2016 | $318,000 | -17.8% | 22,244 | -5.5% | 0.00% | 0.0% |
| Q3 2016 | $387,000 | – | 23,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $2,784,274 | 0.93% |
| CHI Advisors LLC | 2,384,402 | $2,026,742 | 0.54% |
| Telemetry Investments, L.L.C. | 390,000 | $332 | 0.52% |
| Orbimed Advisors | 6,943,654 | $5,902,106 | 0.11% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 548,727 | $466,418 | 0.07% |
| BVF INC/IL | 1,370,947 | $1,165,305 | 0.05% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $54,207 | 0.03% |
| Artal Group S.A. | 500,000 | $425 | 0.02% |
| Hikari Power Ltd | 49,959 | $42 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,300 | $135,405 | 0.00% |